Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

Other drug names:  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  0-9

Leuprolide

(loo proe' lide)

Printer-friendly versionE-mail this page to a friend

Contents of this page:

About your treatment   Return to top

Your doctor has ordered the drug leuprolide to help treat your illness. Leuprolide comes as a solution (Lupron) that is injected subcutaneously (just under the skin) and is usually given once daily. Leuprolide also comes as a long-acting suspension (Eligard) that is injected subcutaneously and is usually given every 1, 3, 4, or 6 months. This medication also comes as a long-acting suspension that is injected intramuscularly (into a muscle) and is usually given once a month (Lupron Depot, Lupron Depot-PED) or every few months (Lupron Depot-3 month, Lupron Depot-4 month). Leuprolide is also available as an implant (a small, thin metal tube containing medication) (Viadur) that is inserted under the skin and is usually given once a year.

Leuprolide is used to treat:

If you receive leuprolide long-acting suspension (Eligard) as a subcutaneous injection, you may notice a small bump when you first receive an injection. This bump should eventually go away.

If you receive leuprolide as an implant under the skin, keep the area where the implant was inserted clean and dry for 24 hours. Do not swim or bathe during this time. Cover the area with a bandage for a few days until the wound heals. Avoid heavy lifting and physical activity for 48 hours after receiving the implant and avoid bumping the area around the implant for a few days.

Leuprolide prescribed for children with precocious puberty will likely be discontinued by your child's doctor before age 11 for girls and age 12 for boys.

Leuprolide is in a class of drugs known as gonadotropin-releasing (GnRH or LH-RH) hormone agonists. It decreases the production of testosterone (male hormone) in men and estrogen (female hormone) in women. Decreasing the production of these hormones is desirable because they stimulate the growth of the diseased cells involved in prostate cancer and endometriosis, and they stimulate the development of sexual characteristics in children with early puberty.

Your doctor will tell you how long your treatment with leuprolide will last. When used to treat advanced prostate cancer, leuprolide controls the symptoms of prostate cancer but does not cure it. Continue to use leuprolide even if you feel well. Do not stop using leuprolide without talking to your doctor.

If your doctor has told you or your caregiver to give a subcutaneous injection of leuprolide, follow these steps:

Other uses for this medicine   Return to top

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Precautions   Return to top

Before taking leuprolide,

Side effects   Return to top

Leuprolide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

There is an increased risk of osteoporosis (condition in which the bones become weak and fragile and can break easily) while using leuprolide. Talk with your doctor about the risks of using leuprolide.

In children receiving leuprolide for early puberty, signs of sexual development may not decrease or may increase during the first few weeks of treatment. In girls receiving leuprolide for early puberty, the onset of menstruation or spotting (light vaginal bleeding) may occur during the first two months of treatment. If bleeding continues beyond the second month, call your doctor.

Leuprolide may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].

Storage conditions   Return to top

If you are receiving leuprolide injections at home, keep leuprolide in the carton it came in and out of reach of children. Keep syringes and needles out of reach of children. Store leuprolide at room temperature and away from light, excess heat (such as a radiator) and moisture (not in the bathroom). Do not allow leuprolide to freeze. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

In case of emergency/overdose   Return to top

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Special instructions   Return to top

Brand names   Return to top

  • Eligard®
  • Lupron®
  • Lupron Depot®
  • Lupron Depot®-3 Month
  • Lupron Depot®-4 Month
  • Lupron Depot-PED®
  • Viadur®

Other names   Return to top

  • Leuprorelin Acetate

Last Revised - 04/01/2006
Last Reviewed - 08/01/2007


ASHP Logo
American Society of Health-System Pharmacists, Inc. Disclaimer

AHFS® Consumer Medication Information. © Copyright, 2008. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.